On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...
As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...
Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback